Clinical Trials Browser

Phase 4 × Imatinib Mesylate × Gastrointestinal × Clear all

NCT01742299 2026-02-02

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Phase 4 Active not recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00510354 2020-09-10

Radix

Phase 4 Completed

GastrointestinalSarcoma

Progressive Gastrointestinal Stromal Tumor

NCT00171977 2012-08-07

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

Phase 4 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors